Skip to main content
Erschienen in: World Journal of Surgery 8/2006

01.08.2006

Covering the Percutaneous Endoscopic Gastrostomy (PEG) Tube Prevents Peristomal Infection

verfasst von: Yutaka Suzuki, MD, Mitsuyoshi Urashima, MD, Yoshio Ishibashi, MD, Masahiro Abo, MD, Hiroshi Mashiko, MD, Yukimoto Eda, MD, Toshiro Kusakabe, MD, Naruo Kawasaki, MD, Katsuhiko Yanaga, MD

Erschienen in: World Journal of Surgery | Ausgabe 8/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

Because oropharyngeal bacteria can be brought through the abdominal wall during percutaneous endoscopic gastrostomy (PEG), peristomal infection is one of the most frequent complications in patients who undergo the procedure. This study aimed to determine whether covering the PEG tube with a sheath that could be detached in the stomach could help prevent peristomal infection.

Methods

In three community hospitals in Japan, data from 449 patients with swallowing dysfunction were prospectively collected between March 2000 and February 2002 for non-covered PEG (n = 206) and between March 2002 and February 2004 for covered PEG (n = 243).

Results

After adjusting for hospital, age, gender, and underlying diseases, covering the PEG significantly reduced peristomal purulent infection compared with non-covered PEG (odds ratio: 0.05; 95% confidence interval: 0.02–0.13). Body temperature, white blood cell count, and C-reactive protein at day 3 after PEG placement, as well as duration of antibiotics usage, were significantly lower or shorter in patients treated with covered PEG than non-covered PEG. In spite of the same frequencies in the two groups of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in oropharyngeal cultures before PEG placement, these organisms were detected significantly less frequently in peristomal lesions of patients who underwent covered PEG. Moreover, 28 patients treated with covered PEG received no antibiotic therapy, and 27 of them had no signs of peristomal infection.

Conclusions

These results suggest that covering the PEG tube, with or without providing antibiotic therapy, may prevent peristomal infection in spite of the presence of oropharyngeal bacterial flora after percutaneous endoscopic gastrostomy.
Literatur
1.
Zurück zum Zitat Gauderer MW, Ponsky JL, Izant RJ Jr. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg 1980;15:872–875PubMed Gauderer MW, Ponsky JL, Izant RJ Jr. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg 1980;15:872–875PubMed
2.
Zurück zum Zitat Ponsky JL, Gauderer MW. Percutaneous endoscopic gastrostomy: a nonoperative technique for feeding gastrostomy. Gastrointest Endosc 1981;27:9–11PubMed Ponsky JL, Gauderer MW. Percutaneous endoscopic gastrostomy: a nonoperative technique for feeding gastrostomy. Gastrointest Endosc 1981;27:9–11PubMed
3.
Zurück zum Zitat Gopalan S, Khanna S. Enteral nutrition delivery technique. Curr Opin Clin Nutr Metab Care 2003;6:313–317PubMedCrossRef Gopalan S, Khanna S. Enteral nutrition delivery technique. Curr Opin Clin Nutr Metab Care 2003;6:313–317PubMedCrossRef
4.
Zurück zum Zitat Nakao FS, Brant CQ, Stanich P, et al. Nutritional status improvement in neurologically impaired patients by percutaneous endoscopic gastrostomy feeding. Arq Gastroenterol 1999;36:148–153PubMed Nakao FS, Brant CQ, Stanich P, et al. Nutritional status improvement in neurologically impaired patients by percutaneous endoscopic gastrostomy feeding. Arq Gastroenterol 1999;36:148–153PubMed
5.
Zurück zum Zitat Lockett MA, Templeton ML, Byrne TK, et al. Percutaneous endoscopic gastrostomy complications in a tertiary-care center. Am Surg 2002;68:117–120PubMed Lockett MA, Templeton ML, Byrne TK, et al. Percutaneous endoscopic gastrostomy complications in a tertiary-care center. Am Surg 2002;68:117–120PubMed
6.
Zurück zum Zitat Treepongkaruna S, Pansrimangkorn W, Pienvichit P, et al. Modified percutaneous endoscopic gastrostomy tubes: experience in Thai children. J Med Assoc Thai 2002;85:S1183–S1190PubMed Treepongkaruna S, Pansrimangkorn W, Pienvichit P, et al. Modified percutaneous endoscopic gastrostomy tubes: experience in Thai children. J Med Assoc Thai 2002;85:S1183–S1190PubMed
7.
Zurück zum Zitat Lee JH, Kim JJ, Kim YH, et al. Increased risk of peristomal wound infection after percutaneous endoscopic gastrostomy in patients with diabetes mellitus. Dig Liver Dis 2002;34:857–861PubMedCrossRef Lee JH, Kim JJ, Kim YH, et al. Increased risk of peristomal wound infection after percutaneous endoscopic gastrostomy in patients with diabetes mellitus. Dig Liver Dis 2002;34:857–861PubMedCrossRef
8.
Zurück zum Zitat Gencosmanoglu R, Koc D, Tozun N. Percutaneous endoscopic gastrostomy: results of 115 cases. Hepatogastroenterology 2003;50:886–888PubMed Gencosmanoglu R, Koc D, Tozun N. Percutaneous endoscopic gastrostomy: results of 115 cases. Hepatogastroenterology 2003;50:886–888PubMed
9.
Zurück zum Zitat Preclik G, Grune S, Leser HG, et al. Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ 1999;319:881–884PubMed Preclik G, Grune S, Leser HG, et al. Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ 1999;319:881–884PubMed
10.
Zurück zum Zitat Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol 2000;95:3133–3136PubMedCrossRef Sharma VK, Howden CW. Meta-analysis of randomized, controlled trials of antibiotic prophylaxis before percutaneous endoscopic gastrostomy. Am J Gastroenterol 2000;95:3133–3136PubMedCrossRef
11.
Zurück zum Zitat Kulling D, Sonnenberg A, Fried M, et al. Cost analysis of antibiotic prophylaxis for PEG. Gastrointest Endosc 2000;51:152–156PubMedCrossRef Kulling D, Sonnenberg A, Fried M, et al. Cost analysis of antibiotic prophylaxis for PEG. Gastrointest Endosc 2000;51:152–156PubMedCrossRef
12.
Zurück zum Zitat Maple PA, Hamilton-Miller JM, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1989;1:537–540PubMedCrossRef Maple PA, Hamilton-Miller JM, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1989;1:537–540PubMedCrossRef
13.
Zurück zum Zitat Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670–1673PubMedCrossRef Hiramatsu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670–1673PubMedCrossRef
14.
Zurück zum Zitat Hull M, Beane A, Bowen J, et al. Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites. Aliment Pharmacol Ther 2001;15:1883–1888PubMedCrossRef Hull M, Beane A, Bowen J, et al. Methicillin-resistant Staphylococcus aureus infection of percutaneous endoscopic gastrostomy sites. Aliment Pharmacol Ther 2001;15:1883–1888PubMedCrossRef
15.
Zurück zum Zitat Mohammed I, Jones BJ. Antibiotic prophylaxis after percutaneous endoscopic gastrotomy insertion. Widespread routine use of prophylactic antibiotics might predispose to increased risk of resistant organisms. BMJ 2000;320:870–871PubMedCrossRef Mohammed I, Jones BJ. Antibiotic prophylaxis after percutaneous endoscopic gastrotomy insertion. Widespread routine use of prophylactic antibiotics might predispose to increased risk of resistant organisms. BMJ 2000;320:870–871PubMedCrossRef
16.
Zurück zum Zitat Kruse A, Misiewicz JJ, Rokkas T, et al. Recommendations of the ESGE workshop on the Ethics of Percutaneous Endoscopic Gastrostomy (PEG) Placement for Nutritional Support. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003. Endoscopy 2003;35:778–780PubMedCrossRef Kruse A, Misiewicz JJ, Rokkas T, et al. Recommendations of the ESGE workshop on the Ethics of Percutaneous Endoscopic Gastrostomy (PEG) Placement for Nutritional Support. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003. Endoscopy 2003;35:778–780PubMedCrossRef
17.
Zurück zum Zitat Deitel M, Bendago M, Spratt EH, et al. Percutaneous endoscopic gastrostomy by the “pull” and “introducer” methods. Can J Surg 1988;31:102–104PubMed Deitel M, Bendago M, Spratt EH, et al. Percutaneous endoscopic gastrostomy by the “pull” and “introducer” methods. Can J Surg 1988;31:102–104PubMed
18.
Zurück zum Zitat Maetani I, Tada T, Ukita T, et al. PEG with introducer or pull method: a prospective randomized comparison. Gastrointest Endosc 2003;57:837–841PubMedCrossRef Maetani I, Tada T, Ukita T, et al. PEG with introducer or pull method: a prospective randomized comparison. Gastrointest Endosc 2003;57:837–841PubMedCrossRef
19.
Zurück zum Zitat Akkersdijk WL, van Bergeijk JD, van Egmond T, et al. Percutaneous endoscopic gastrostomy (PEG): comparison of push and pull methods and evaluation of antibiotic prophylaxis. Endoscopy 1995;27:313–316PubMedCrossRef Akkersdijk WL, van Bergeijk JD, van Egmond T, et al. Percutaneous endoscopic gastrostomy (PEG): comparison of push and pull methods and evaluation of antibiotic prophylaxis. Endoscopy 1995;27:313–316PubMedCrossRef
20.
Zurück zum Zitat Angus F, Burakoff R. The percutaneous endoscopic gastrostomy tube. Medical and ethical issues in placement. Am J Gastroenterol 2003;98:272–277PubMed Angus F, Burakoff R. The percutaneous endoscopic gastrostomy tube. Medical and ethical issues in placement. Am J Gastroenterol 2003;98:272–277PubMed
21.
Zurück zum Zitat Mamel JJ. Percutaneous endoscopic gastrostomy. Am J Gastroenterol 1989;84:703–710PubMed Mamel JJ. Percutaneous endoscopic gastrostomy. Am J Gastroenterol 1989;84:703–710PubMed
22.
Zurück zum Zitat Working group: Rey JR, Axon A, et al. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) Antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy 1998;30:318–324 Working group: Rey JR, Axon A, et al. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) Antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy 1998;30:318–324
23.
Zurück zum Zitat Gossner L, Keymling J, Hahn EG, et al. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial. Gastroenterology 1997;112:A877 (abstract) Gossner L, Keymling J, Hahn EG, et al. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial. Gastroenterology 1997;112:A877 (abstract)
24.
Zurück zum Zitat Rimon E. The safety and feasibility of percutaneous endoscopic gastrostomy placement by a single physician. Endoscopy 2001;33:241–244PubMedCrossRef Rimon E. The safety and feasibility of percutaneous endoscopic gastrostomy placement by a single physician. Endoscopy 2001;33:241–244PubMedCrossRef
25.
Zurück zum Zitat Lin HS, Ibrahim HZ, Kheng JW, et al. Percutaneous endoscopic gastrostomy: strategies for prevention and management of complications. Laryngoscope 2001;111:1847–1852PubMedCrossRef Lin HS, Ibrahim HZ, Kheng JW, et al. Percutaneous endoscopic gastrostomy: strategies for prevention and management of complications. Laryngoscope 2001;111:1847–1852PubMedCrossRef
26.
Zurück zum Zitat Chaudhary KA, Smith OJ, Cuddy PG, et al. PEG site infections: the emergence of methicillin resistant Staphylococcus aureus as a major pathogen. Am J Gastroenterol 2002;97:1713–1716PubMedCrossRef Chaudhary KA, Smith OJ, Cuddy PG, et al. PEG site infections: the emergence of methicillin resistant Staphylococcus aureus as a major pathogen. Am J Gastroenterol 2002;97:1713–1716PubMedCrossRef
Metadaten
Titel
Covering the Percutaneous Endoscopic Gastrostomy (PEG) Tube Prevents Peristomal Infection
verfasst von
Yutaka Suzuki, MD
Mitsuyoshi Urashima, MD
Yoshio Ishibashi, MD
Masahiro Abo, MD
Hiroshi Mashiko, MD
Yukimoto Eda, MD
Toshiro Kusakabe, MD
Naruo Kawasaki, MD
Katsuhiko Yanaga, MD
Publikationsdatum
01.08.2006
Erschienen in
World Journal of Surgery / Ausgabe 8/2006
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-0628-2

Weitere Artikel der Ausgabe 8/2006

World Journal of Surgery 8/2006 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.